RP
UTHR icon

Richard Pzena’s United Therapeutics UTHR Stock Holding History

Richard Pzena’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,599
Closed -$509K – 166
2024
Q2 		$509K Sell
1,599
-498
-24% -$132K ﹤0.01% 142
2024
Q1 		$482K Buy
2,097
+75
+4% +$16.9K ﹤0.01% 143
2023
Q4 		$445K Buy
2,022
+159
+9% +$36.6K ﹤0.01% 152
2023
Q3 		$421K Sell
1,863
-211
-10% -$48.6K ﹤0.01% 147
2023
Q2 		$458K Buy
2,074
+369
+22% +$81.7K ﹤0.01% 146
2023
Q1 		$382K Buy
+1,705
New +$420K ﹤0.01% 150
2022
Q2 		– Sell
-2,768
Closed -$497K – 178
2022
Q1 		$497K Buy
2,768
+181
+7% +$34.5K ﹤0.01% 152
2021
Q4 		$559K Sell
2,587
-209
-7% -$41K ﹤0.01% 150
2021
Q3 		$516K Buy
2,796
+500
+22% +$98.5K ﹤0.01% 150
2021
Q2 		$412K Buy
+2,296
New +$437K ﹤0.01% 158
2021
Q1 		– Sell
-4,289
Closed -$651K – 182
2020
Q4 		$651K Sell
4,289
-804
-16% -$106K ﹤0.01% 147
2020
Q3 		$514K Sell
5,093
-185
-4% -$20.3K ﹤0.01% 156
2020
Q2 		$639K Buy
+5,278
New +$594K ﹤0.01% 157

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Richard Pzena's UTHR Position: Q3 2024 in Review

Richard Pzena sold out of United Therapeutics (UTHR) in Q3 2024, closing a stake of 1,599 shares — an estimated $509K sold.

Richard Pzena first reported a position in UTHR in Q2 2020 and held it in 13 quarters. The position peaked at $651K in Q4 2020. 625 funds tracked by Wall St. Rank hold UTHR as of Q3 2024.

  • Richard Pzena reported no remaining United Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Richard Pzena sold 1,599 United Therapeutics shares in Q3 2024, an estimated $509K.
  • Richard Pzena first reported a position in United Therapeutics in Q2 2020 and held it in 13 quarters.
  • Richard Pzena's United Therapeutics position peaked at $651K in Q4 2020.
  • 625 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2024.

Based on Pzena Investment Management's 13F filing for Q3 2024, filed 8 Nov 2024.